Learn Mode

DGX - Quest Diagnostics Inc

38

$195.02

$3.56 (1.859%)

At market close

$195.08

$0.06 (0.029%)

After Hours 4/17/26, 9:48 PM

Score

3.64/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

DGX

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$21.43B

Industry

Health Care

EPS (TTM)

$8.74

P/E (TTM)

21.69

Div & Yield

$3.44 (1.76%)

FCF Payout Ratio

27.81%

P/S (TTM)

1.94

P/B

2.99

Diluted Shares

113.00M

Ex-Dividend

2026-04-06

Next Earnings

04-21

Forward P/E

18.00

Payout Ratio

38.25%

P/FCF (TTM)

15.77

FCF Yield

6.34%

Earnings Yield

4.61%

52 Week Range

Score Card

Explore Scores Tab

3.64

Good

Quest Diagnostics Inc has grown revenue at 11.78% over the past year, which is strong growth. Also, it has seen its diluted average shares outstanding decrease by -2.59% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

2.00

Bad

Management

4.00

Good

Growth

5.00

Very Good

Profitability

1.00

Very Bad

Fin. Health

1.00

Very Bad

Dividends

5.00

Very Good

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

Filter Form Types

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-04-06 16:33:23

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-04-06 16:32:10

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-02 17:16:56

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-27 11:36:26

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-12 16:30:56

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-11 18:05:01

Form 3

Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-03-11 18:03:47

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 16:45:16

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 16:45:04

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 16:44:45

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 16:44:30

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 16:44:18

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-07

High:

$246.75

26.5%

Avg:

$220.47

13.0%

Low:

$169.00

-13.3%

(% change is relative to the current stock price: $195.02)

Analyst Recommendations

Go to Analyst Tab

3.79

Good

25%

Strong Buy (6)

29%

Buy (7)

46%

Hold (11)

Sell (0)

Strong Sell (0)

About

Website
https://www.questdiagnostics.com/
Address
500 Plaza Drive, Secaucus NEW JERSEY, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1022079

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 46,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

IPO Date

1996-12-17

Industry

Health Care

Total Employees

51,500

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Health Care Providers & Services

GICS Sub

Health Care Services

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

DGX - Quest Diagnostics Inc

38

$195.02

$3.56 (1.859%)

$195.08

$0.06 (0.029%)

3.64/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form DEFA14A

Filed on 2026-04-06 16:33:23

Form DEF 14A

Filed on 2026-04-06 16:32:10

Form 4

Filed on 2026-04-02 17:16:56

Form SCHEDULE 13G/A

Filed on 2026-03-27 11:36:26

Form 8-K

Filed on 2026-03-12 16:30:56

Form 4

Filed on 2026-03-11 18:05:01

Form 3

Filed on 2026-03-11 18:03:47

Form 4

Filed on 2026-03-06 16:45:16

Form 4

Filed on 2026-03-06 16:45:04

Form 4

Filed on 2026-03-06 16:44:45

Form 4

Filed on 2026-03-06 16:44:30

Form 4

Filed on 2026-03-06 16:44:18

Financials

Price Targets

26.5%

13.0%

-13.3%

Analyst Recommendations

About

Similar Stocks